Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 819
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07487818 A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking … |
Non-invasive vagus nerve stimulat… | SEP | Phase 2/3 | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2026-06-04 → 2028-07 | Ouvrir |
| NCT06822140 EVAMOS — Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor a… |
transcutaneous auricular vagus ne… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Rheinburg-Klinik | Switzerland · Rheinburg Klinik, Walzenenhausen, Switz… | 2025-04-01 → 2028-04-30 | Ouvrir |
| NCT03217929 Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Cravi… |
Active-taVNS | SEP | Non applicable | UNKNOWN | En attente / non publié | Federal University of São Paulo | Brazil · Federal University of São Paulo, São Paulo, … | 2017-10 → 2019-10 | Ouvrir |
| NCT02974959 Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury |
gammaCore active device | SEP | Phase 1 | COMPLETED | En attente / non publié | CentraCare | United States · Hennepin County Medical Center, Minne… | 2016-10 → 2020-11 | Ouvrir |
| NCT06871306 Effects of Left and Bilateral Transcutaneous Auricular Vagus Nerve Stim… |
transcutaneous auricular vagus ne… | SEP | Non applicable | COMPLETED | En attente / non publié | Rheinburg-Klinik | Turkey (Türkiye) · Sancak Tıp Merkezi, Istanbul, Turk… | 2021-08-02 → 2022-10-31 | Ouvrir |
| NCT05588063 kidNEY-VNS — taVNS for FRNS in Children |
transcutaneous auricular vagus ne… | SEP | Non applicable | RECRUITING | En attente / non publié | Rheinburg-Klinik | United States · Children's Hospital of Philadelphia, … | 2023-01-05 → 2027-08-01 | Ouvrir |
| NCT06812585 The Effect of Metformin As an Adjuvant Therapy on Immunological Paramet… |
Metformin (Cidophage®) | SEP | Phase 2 | COMPLETED | En attente / non publié | German University in Cairo | Egypt · Nasser Institute for Research and Treatment, … | 2022-04-01 → 2025-01-30 | Ouvrir |
| NCT02688985 Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biol… |
Ocrelizumab | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Canada, Germany, Sweden · Empire Neuro… | 2016-04-29 → 2023-04-11 | Ouvrir |
| NCT05156281 REMODEL-2 — Efficacy and Safety of Remibrutinib Compared to Teriflunomi… |
Remibrutinib | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, Bulgaria, Canada, C… | 2021-12-13 → 2030-10-30 | Ouvrir |
| NCT07932262 An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CAR… |
CAR-T cells targeting CD19 | SEP | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | University Hospital Tuebingen | Germany · University Hospital , Department of Interna… | 2027-01 → 2028-09 | Ouvrir |
| NCT05925049 A Study Utilising Data From European Union (EU) National Multiple Scler… |
natalizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Biogen | United States · Research Site, Cambridge, United Stat… | 2023-06-30 → 2026-10-29 | Ouvrir |
| NCT07930624 A Study to Investigate Long-term Safety and Tolerability of Frexalimab … |
Frexalimab | SEP | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Sanofi | Non communiqué | 2027-02-15 → 2031-05-16 | Ouvrir |
| NCT07067463 A Study of Orelabrutinib in Patients With Primary Progressive Multiple … |
Orelabrutinib | SEP | Phase 3 | RECRUITING | En attente / non publié | Liu Qing | United States, Australia, Bulgaria, Canada, Croatia, … | 2026-03-23 → 2030-07 | Ouvrir |
| NCT06733922 ELIOS - Investigational Biomarkers to Track Disease Modification in Act… |
ETNATM-ProgMS | SEP | Phase 4 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Canada · Novartis Investigative Site, Burnaby, Canada… | 2024-11-27 → 2029-03-31 | Ouvrir |
| NCT06900192 A Multicenter Phase 1 Study of Orca-Q in Primary Progressive Multiple S… |
Orca-Q | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Orca Biosystems, Inc. | Non communiqué | 2027-03 → 2032-12 | Ouvrir |
| NCT05245344 Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration … |
peripheral blood withdrawal | SEP | À vérifier | COMPLETED | En attente / non publié | Neuromed IRCCS | Italy · Centre for Experimental Neurological Therapie… | 2023-01-15 → 2023-10-31 | Ouvrir |
| NCT07935031 A Study of IMS001 in Patients With Multiple Sclerosis |
IMS001 | SEP | Phase 1 | RECRUITING | En attente / non publié | Zhuhai Hengqin ImStem Biotechnolo… | China · West China Hospital, Sichuan University, Chen… | 2026-09-28 → 2029-12 | Ouvrir |
| NCT06292923 A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple… |
Foralumab | SEP | Phase 2 | COMPLETED | En attente / non publié | Tiziana Life Sciences LTD | United States · Brigham and Women's Hospital, Boston,… | 2023-11-15 → 2026-09-17 | Ouvrir |
| NCT04650321 Home Based Infusions for Ocrelizumab |
Ocrelizumab at home | SEP | Phase 4 | RECRUITING | En attente / non publié | University of Colorado, Denver | United States · Amerita, Centennial, United States | 2021-03-01 → 2021-08-31 | Ouvrir |
| NCT04640818 Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy |
Cladribine Oral Tablet | SEP | À vérifier | UNKNOWN | En attente / non publié | Claudio Gobbi | Switzerland · Neurocenter of Southern Switzerland, Os… | 2020-12-17 → 2022-10-31 | Ouvrir |
| NCT06529406 COAST — Prospective Evaluation of Sequencing From antiCD-20 Therapies t… |
Ozanimod | SEP | Phase 4 | RECRUITING | En attente / non publié | University of Colorado, Denver | United States · Cleveland Clinic, Cleveland, United S… | 2024-07-29 → 2029-08-01 | Ouvrir |
| NCT06141486 FREVIVA — Efficacy and Safety Study of Frexalimab (SAR441344) in Adults… |
Frexalimab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sanofi | United States, Argentina, Australia, Belgium, Brazil,… | 2023-12-27 → 2028-03-24 | Ouvrir |
| NCT04480853 SPRING — Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥… |
Fingolimod | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Taiwan · Novartis Investigative Site, Kaohsiung City,… | 2020-10-12 → 2026-11-15 | Ouvrir |
| NCT04178005 Cladribine Tablets After Treatment With Natalizumab (CLADRINA) |
Cladribine | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · College Park Family Care Center Physi… | 2020-02-19 → 2027-08 | Ouvrir |
| NCT07914257 Non-invasive Brain Stimulation to Improve Memory in Multiple Sclerosis |
High Definition transcranial Dire… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | The University of Texas at Dallas | United States · Callier Clinical Researcher Center, R… | 2026-11-01 → 2029-09-01 | Ouvrir |